E. Llop

发表

Consensus Statement on Hemostatic Management, Anticoagulation, and Antiplatelet Therapy in Liver Transplantation

S. Bonanad, L. Lladó, E. Montalvá, 2022, Transplantation.

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.

M. Ronot, V. Vilgrain, J. García‐Pagán, 2019, Journal of hepatology.

Comparison of non- invasive fibrosis scores to predict increased liver stiffness in the general population with unknown liver disease: Searching for the primary physician's best friend.

Marta Hernández, J. Calleja, J. Abad, 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort

J. Calleja, J. Crespo, M. Serra, 2021, United European gastroenterology journal.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

X. Forns, J. Calleja, J. García‐Pagán, 2020, Journal of hepatology.

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

X. Forns, J. Calleja, J. García‐Pagán, 2017, Gastroenterology.

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end‐stage liver disease: Analysis of data from the Hepa‐C registry

M. Buti, M. L. de la Mata, J. Calleja, 2017, Hepatology.

J. Bosch, J. García‐Pagán, A. Cárdenas, 2017, Hepatology.

REPLY TO HEP-16-2222

A. Cárdenas, C. Villanueva, O. Pavel, 2017 .

Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial

J. Bosch, J. García‐Pagán, A. Cárdenas, 2016, Hepatology.

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

M. Rudler, D. Thabut, F. Nevens, 2018, Hepatology.

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

M. Poca, J. Calleja, J. Genescà, 2021, Journal of clinical medicine.

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals †

S. Resino, L. Ibáñez-Samaniego, M. Jiménez-Sousa, 2020, Journal of clinical medicine.

Impact of sustained viral response in the evolution of minimal hepatic encephalopathy: A prospective pilot study.

J. Calleja, C. Perelló, C. Fernández-Carrillo, 2019, Annals of hepatology.

Impact of Sustained Viral Response in the Evolution of Minimal Hepatic Encephalopathy: a Prospective Pilot Study.

J. Calleja, C. Perelló, C. Fernández-Carrillo, 2019, Annals of hepatology.

[Treatment of non-cirrhotic, non-tumoural portal vein thrombosis].

S. Seijo, E. Llop, Susana Seijo, 2016 .

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

M. Rudler, D. Thabut, F. Nevens, 2021, Journal of hepatology.

The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.

J. Fuster, J. García-Valdecasas, G. Martínez-Pallí, 2019, Journal of hepatology.

Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do

S. Llerena, J. Calleja, J. Crespo, 2020, Journal of viral hepatitis.

Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48.

J. Calleja, B. Peñas, L. Abreu, 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Portal cholangiopathy: radiological classification and natural history

J. García‐Pagán, J. Bosch, S. Seijo, 2011, Gut.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

M. Rudler, D. Thabut, F. Nevens, 2022, Gut.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

M. Rudler, D. Thabut, F. Nevens, 2020, Journal of hepatology.

Non-invasive tests for clinically significant portal hypertension after HCV cure.

H. Yoshiji, X. Forns, E. Tsochatzis, 2022, Journal of hepatology.

Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.

J. Bosch, Hélène Larrue, C. Bureau, 2022, Journal of hepatology.

A MELD-based model to determine risk of mortality among patients with acute variceal bleeding.

P. Tandon, A. Berzigotti, J. Genescà, 2014, Gastroenterology.

Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain

J. Lazarus, J. Llorca, S. Llerena, 2019, Journal of viral hepatitis.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Arterioportal fistula, a rare cause of presinusoidal portal hypertension.

Marta Hernández, J. Calleja, E. Llop, 2016, Gastroenterologia y hepatologia.

I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.

Jordi Espadaler Mazo, J. Serra, V. Lorenzo-Zúñiga, 2014, World journal of gastroenterology.

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

C. Strassburg, D. Toth, J. Trebicka, 2020, Journal of hepatology.

Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

D. Toth, J. Trebicka, W. Laleman, 2018, Gastroenterology.

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

M. Casas, J. García‐Pagán, J. Genescà, 2015, Hepatology.

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, Clinical Gastroenterology and Hepatology.

Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps.

Alberto Álvarez, Francisco Javier García-Alonso, Antonio Z. Gimeno-García, 2019, Gastroenterology.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors.

J. Bruix, J. Bosch, A. Berzigotti, 2012, Journal of hepatology.

Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial

J. Calleja, J. Abad, C. Perelló, 2021, The American journal of gastroenterology.

A NEW COMBINATION OF PROBIOTICS , IMPROVES IRRITABLE BOWEL SYNDROME-RELATED QUALITY OF LIFE . A PILOT , DOSE-FINDING , MULTICENTER , DOUBLE BLIND , PLACEBO-CONTROLLED CLINICAL TRIAL

Jordi Espadaler Mazo, J. Serra, L. Abreu, 2014 .

Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease.

X. Forns, J. Trebicka, W. Laleman, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Spleen Stiffness: The "New Kid on the Block" in the Diagnosis of Clinical Significant Portal Hypertension.

J. Calleja, E. Llop, 2023, Journal of clinical and experimental hepatology.

Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease

Marta Hernández, J. Calleja, J. Revilla, 2017, Journal of gastroenterology and hepatology.

Visceral fat is associated with cirrhotic portal vein thrombosis

J. Calleja, J. Abad, C. Perelló, 2019, Expert review of gastroenterology & hepatology.

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case‐control study

J. Bosch, I. Araujo, J. Genescà, 2013, Hepatology.

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

M. Poca, J. Calleja, J. Lozano, 2023, Hepatology.

Insulin resistance in patients with cirrhosis and portal hypertension.

I. Conget, A. Berzigotti, J. García‐Pagán, 2012, American journal of physiology. Gastrointestinal and liver physiology.

Spleen Transient Elastography and Damping Index Identify a Subgroup of Patients Without an Acute or Chronic Response to Beta-Blockers

J. Calleja, T. Fontanilla, J. Abad, 2022, Frontiers in Medicine.

Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease

J. Abad, C. Perelló, E. Fraga, 2020, World journal of gastroenterology.

M. Rudler, D. Thabut, F. Nevens, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Treatment of Hepatitis C Virus in Patients with Advanced Cirrhosis: Always Justified? Analysis of the Hepa-C Registry

J. J. Moreno, M. Buti, J. Calleja, 2016 .

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

J. Ampuero, G. Casanovas, J. Genescà, 2023, Journal of Hepatology.

Non‐malignant portal vein thrombosis in a cohort of cirrhotic patients: Incidence and risk factors

J. Calleja, J. Crespo, J. Abad, 2021, Hepatology research : the official journal of the Japan Society of Hepatology.

[Treatment of non-cirrhotic, non-tumoural portal vein thrombosis].

S. Seijo, E. Llop, 2016, Gastroenterologia y hepatologia.

Preemptive-TIPS improves outcome in high-risk variceal bleeding An observational study

M. Rudler, D. Thabut, F. Nevens, 2018 .

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case‐control study

J. Bosch, I. Araujo, J. Genescà, 2013, Hepatology.

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.

V. de Lédinghen, Wen-Yue Liu, G. Goh, 2024, JAMA.

Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.

J. García‐Pagán, M. Alonso-Peña, M. Magaz, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.

V. de Lédinghen, Wen-Yue Liu, G. Goh, 2024, Gut.